Related Experiment Video
Updated: May 4, 2026
12:14
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
Published on: February 12, 2016
35.2K
Correlation Between Cystatin-C and Interleukin-34 Expression Detection and Post-Stroke Cognitive Impairment
Xinlei Wang1, Weina Guo1, Jinye Zhao1
11st Department of Internal Medicine-Neurology, Baoding No.1 Central Hospital, Hebei, China.
Summary
This study found that higher levels of Cystatin-C (Cys-C) and Interleukin-34 (IL-34) are linked to cognitive impairment after a stroke. These biomarkers may help identify patients at risk for post-stroke cognitive dysfunction.
Area of Science:
- Neurology
- Biochemistry
- Medical Research
Background:
- Post-stroke cognitive impairment (PSCI) is a significant complication affecting patient recovery and quality of life.
- Biomarkers for predicting PSCI are crucial for early intervention and management.
- Cystatin-C (Cys-C) and Interleukin-34 (IL-34) have been implicated in various neurological conditions.
Purpose of the Study:
- To investigate the association between serum levels of Cys-C and IL-34 and the presence of cognitive impairment in stroke patients.
- To determine if Cys-C and IL-34 can serve as predictive markers for PSCI.
Main Methods:
- A retrospective study involving 300 stroke patients (109 with PSCI, 191 without).
- Comparison of Cys-C and IL-34 expression levels between PSCI and non-PSCI groups.
- Correlation and multivariate analyses to assess the relationship between biomarkers and cognitive dysfunction.
Main Results:
- Statistically significant differences in Cys-C and IL-34 levels were observed between the groups.
- Both Cys-C (r = 0.192, p = 0.001) and IL-34 (r = 0.393, p < 0.001) showed a significant correlation with cognitive impairment.
- Multivariate analysis identified Cys-C (OR = 6.768, p = 0.016) and IL-34 (OR = 0.049, p = 0.002) as independent risk factors for post-stroke cognitive dysfunction.
Conclusions:
- Elevated Cys-C and altered IL-34 expression are significantly associated with cognitive impairment following a stroke.
- Cys-C and IL-34 hold potential as valuable biomarkers for identifying stroke patients at risk of cognitive decline.
- Further research is warranted to explore the therapeutic implications of targeting these pathways in PSCI.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35